| The immune landscape of cancer V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ... Immunity 48 (4), 812-830. e14, 2018 | 4346 | 2018 |
| Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline JWM Lenders, QY Duh, G Eisenhofer, AP Gimenez-Roqueplo, ... The Journal of Clinical Endocrinology & Metabolism 99 (6), 1915-1942, 2014 | 2698 | 2014 |
| An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics J Liu, T Lichtenberg, KA Hoadley, LM Poisson, AJ Lazar, AD Cherniack, ... Cell 173 (2), 400-416. e11, 2018 | 2541 | 2018 |
| Oncogenic signaling pathways in the cancer genome atlas F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ... Cell 173 (2), 321-337. e10, 2018 | 2397 | 2018 |
| Comprehensive characterization of cancer driver genes and mutations MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ... Cell 173 (2), 371-385. e18, 2018 | 2132 | 2018 |
| Phaeochromocytoma JWM Lenders, G Eisenhofer, M Mannelli, K Pacak The Lancet 366 (9486), 665-675, 2005 | 2121 | 2005 |
| Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer KA Hoadley, C Yau, T Hinoue, DM Wolf, AJ Lazar, E Drill, R Shen, ... Cell 173 (2), 291-304. e6, 2018 | 2000 | 2018 |
| Biochemical diagnosis of pheochromocytoma: which test is best? JWM Lenders, K Pacak, MCM Walther, WM Linehan, M Mannelli, ... Jama 287 (11), 1427-1434, 2002 | 1597 | 2002 |
| Machine learning identifies stemness features associated with oncogenic dedifferentiation TM Malta, A Sokolov, AJ Gentles, T Burzykowski, L Poisson, JN Weinstein, ... Cell 173 (2), 338-354. e15, 2018 | 1555 | 2018 |
| Stressor specificity of central neuroendocrine responses: implications for stress-related disorders K Pacak, M Palkovits Endocrine reviews 22 (4), 502-548, 2001 | 1389 | 2001 |
| Genomic and molecular landscape of DNA damage repair deficiency across the cancer genome atlas TA Knijnenburg, L Wang, MT Zimmermann, N Chambwe, GF Gao, ... Cell reports 23 (1), 239-254. e6, 2018 | 902 | 2018 |
| Irisin and FGF21 are cold-induced endocrine activators of brown fat function in humans P Lee, JD Linderman, S Smith, RJ Brychta, J Wang, C Idelson, RM Perron, ... Cell metabolism 19 (2), 302-309, 2014 | 875 | 2014 |
| Genomic and functional approaches to understanding cancer aneuploidy AM Taylor, J Shih, G Ha, GF Gao, X Zhang, AC Berger, SE Schumacher, ... Cancer cell 33 (4), 676-689. e3, 2018 | 842 | 2018 |
| Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma K Pacak, WM Linehan, G Eisenhofer, MCM Walther, DS Goldstein Annals of internal medicine 134 (4), 315-329, 2001 | 835 | 2001 |
| Pheochromocytoma: recommendations for clinical practice from the First International Symposium K Pacak, G Eisenhofer, H Ahlman, SR Bornstein, AP Gimenez-Roqueplo, ... Nature clinical practice Endocrinology & metabolism 3 (2), 92-102, 2007 | 821 | 2007 |
| The cancer genome atlas comprehensive molecular characterization of renal cell carcinoma CJ Ricketts, AA De Cubas, H Fan, CC Smith, M Lang, E Reznik, R Bowlby, ... Cell reports 23 (1), 313-326. e5, 2018 | 815 | 2018 |
| Spatial organization and molecular correlation of tumor-infiltrating lymphocytes using deep learning on pathology images J Saltz, R Gupta, L Hou, T Kurc, P Singh, V Nguyen, D Samaras, ... Cell reports 23 (1), 181-193. e7, 2018 | 810 | 2018 |
| Cushing’s syndrome due to ectopic corticotropin secretion: twenty years’ experience at the National Institutes of Health I Ilias, DJ Torpy, K Pacak, N Mullen, RA Wesley, LK Nieman The Journal of Clinical Endocrinology & Metabolism 90 (8), 4955-4962, 2005 | 809 | 2005 |
| Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction BA Borlaug, V Melenovsky, SD Russell, K Kessler, K Pacak, LC Becker, ... Circulation 114 (20), 2138-2147, 2006 | 787 | 2006 |
| Comprehensive analysis of alternative splicing across tumors from 8,705 patients A Kahles, KV Lehmann, NC Toussaint, M Hüser, SG Stark, ... Cancer cell 34 (2), 211-224. e6, 2018 | 701 | 2018 |
